MRNA Moderna Inc.

+0.13  (+1%)
Previous Close 19
Open 19
Price To Book 4.11
Market Cap 6293778972
Shares 329,000,469
Volume 405,961
Short Ratio
Av. Daily Volume 951,131

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 completed.
Myocardial ischemia
Phase 1 completed.
Solid tumors, lymphoma
Phase 2 trial planned.
mRNA-4157 - KEYNOTE-603
Personalized cancer vaccine
Phase 1 completed.
Chikungunya vaccine
Phase 1 completed.
Influenza vaccine
Phase 1 completed.
Influenza vaccine
Phase 1 ongoing.
Human Metapneumovirus and Human Parainfluenza Infection (hMPV+PIV3 vaccine)
Phase 1 ongoing.
CMV vaccine (Cytomegalovirus Infection)
Phase 1 completed.
RSV vaccine
Phase 1/2 trial planned.
Methylmalonic Acidemia (MMA)
Phase 1 dosing has commenced - noted January 8, 2019.
Solid tumors, lymphoma
Phase 1 initiation of dosing announced February 5, 2019.
Chikungunya Virus Infection

Latest News

  1. Cambridge VC Flagship raises $824M for new life science investments
  2. Moderna Inc (MRNA) Files 10-K for the Fiscal Year Ended on December 31, 2018
  3. How Much Of Moderna, Inc. (NASDAQ:MRNA) Do Insiders Own?
  4. Moderna Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights Recent Pipeline Progress
  5. Cramer: Investors can find a better entry point on these recent IPOs
  6. Moderna to Present at Upcoming Investor Conferences in March
  7. Moderna to Report Fourth Quarter and Full Year 2018 Financial Results on Wednesday, March 6, 2019
  8. Phase 1 Data Published in Nature Communications Show Potential of mRNA Encoding VEGF-A as a Regenerative Therapeutic
  9. Andreas Halvorsen's 5 Largest Stock Buys in 4th Quarter
  10. Moderna's Small Base Could Surprise on the Upside
  11. Is Moderna a Buy?
  12. The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering
  13. Moderna reports early success in respiratory infection vaccine
  14. Moderna Announces Positive Interim Phase 1 Data for First Combination Vaccine Against the Respiratory Viruses hMPV and PIV3
  15. Moderna Announces Dosing of the First Monoclonal Antibody Encoded by mRNA in a Clinical Trial
  16. Cramer's lightning round: Bank of America's stock is a screaming buy
  17. Cramer's lightning round: Bank of America's stock is a screaming buy
  18. Here's Why Moderna Jumped 9.7% on Thursday
  19. Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and Moderna